Unknown

Dataset Information

0

Intensive Home Care for COVID-19 to Reduce Admissions


ABSTRACT: Hospitalization for COVID-19 has placed a significant financial and logistical burden on hospitals and health care systems. Limitations on visitation and isolation precautions have made hospitalization more isolating for patients in the time of COVID-19. Increasing the provision of healthcare delivered at home has the potential to decrease healthcare costs by providing care at home which may be preferred for many patients. We describe a series of 39 patients who were treated with intravenous remdesivir at home in addition to oxygen, dexamethasone, and anticoagulants. These patients were at high risk for decompensation due to COVID-19 and met accepted criteria for admission—need for supplemental oxygen and intravenous remdesivir. All patients had home lab monitoring and frequent telehealth visits. Over the study period 13 (33%) of patients were admitted for worsening COVID-19 and 5 (13%) died. Twenty-six patients avoided admission, and none experienced a severe adverse effect from in-home treatment. The expanded use of telehealth services due to the COVID-19 pandemic has the potential to increase the frequency of patient monitoring by physicians and the provision of care and monitoring usually restricted to hospitalized patients.

SUBMITTER: Aviv R 

PROVIDER: S-EPMC8335407 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2022-03-03 | PXD029009 | Pride
| S-EPMC7640529 | biostudies-literature
| S-EPMC7704189 | biostudies-literature
| S-EPMC8013188 | biostudies-literature
2021-11-17 | GSE176498 | GEO
| S-EPMC7766471 | biostudies-literature
| S-EPMC8619872 | biostudies-literature
| S-EPMC7840596 | biostudies-literature
| S-EPMC8080965 | biostudies-literature
| S-EPMC7568687 | biostudies-literature